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ABSTRACT  
Objective: The aim of this study is to explore the possible effects of drug solubility and commercial supply sources of HPMC and PVP on physical 
properties of matrix tablets. 
Methods: Two different supply sources (A and B) for Hydroxy Propyl Methyl Cellulose (HPMC) as matrix forming polymer and Polyvinyl 
Pyrrilidone (PVP) as matrix supportive polymer were used with either Chlorphenaramine maleate (CPM), as a water soluble drug or Atenolol 
(ATN), as a water insoluble drug, to produce a series of matrix formulations using direct compression according to a 23
Results: Matrix hardness and friability properties demonstrated to be influenced by PVP supply source as an individual factor alone or in 
combination with drug solubility factor, moreover, both properties were found to be less affected by drug solubility and HPMC supply source, as 
individual factors. Compared to other factors, drug solubility was found to have a substantial influence on drug dissolution efficiency (DE) and 
diffusion exponent of the drug release (n) of different matrices. 
 full factorial design. Matrices 
were then qualified for friability, hardness, and drug release attributes. 
Conclusion: Variation in commercial PVP supply source and drug solubility could possibly result in matrices with different physical performance. 
Keywords: Drug solubility, HPMC supply source, PVP supply source, Matrix hardness, Matrix friability, Matrix release. 
 
INTRODUCTION 
Polymers are substances or materials that have a high molecular 
weight and consisting of repeated units named as monomers. 
Pharmaceutical applications of polymers are numerous and cover a 
wide range of utility [1,2]. This might be attributed to their 
biodegradability, pharmacological inertness, compatibility and low 
cost. The wide range of physicochemical properties offered by these 
materials may be utilized to improve both the clinical and non clinical 
(e. g., manufacturing, stability) properties of dosage forms. 
Polymers can be categorized into two classes, water soluble 
(hydrophilic) and water insoluble (hydrophobic) polymers. 
Hydroxypropyl methyl cellulose (hypromellose, HPMC) is a 
hydrophilic polymer available in several grades that vary in viscosity 
and extent of substitution. It is widely used in oral, ophthalmic and 
topical pharmaceutical formulations [3]. 
Polyvinylpyrrolidinone (PVP) is a hydrophilic polymer available in 
several grades. In addition to utilization of PVP in tablets production, 
it is used as a suspending, stabilizing, or viscosity increasing agent in 
a number of topical and oral suspensions and solutions. 
Incorporation of a drug in a polymeric matrix is one of the methods 
to develop controlled release dosage forms. The widespread 
application of the matrix as a dosage form for non conventional drug 
delivery is attributed to simplicity, versatility and reproducibility of 
its fabrication method.  
Numerous researches dealing with the pharmaceutical application 
of HPMC in matrices for sustained release drug delivery have been 
reported [4-6] and addition of PVP-K30 in HPMC-based matrix is 
believed to support the matrix for constant drug release through 
enhancing swelling-erosion balance of the matrix [7]. 
Many factors have been reported to affect the performance and drug 
release of matrix tablets [8,9]. However, the individual or mutual 
influences of drug solubility and the commercial supply source of 
polymers on matrix performance have received less attention 
among formulation scientists.  
The objective of this study is to explore the possible effects of drug 
solubility and supply source of included polymers (HPMC K4M and 
PVP K-30) on the characteristics of matrix tablets using Atenolol and 
Chlorpheneramine maleate as sparingly and free water soluble 
model drugs, respectively. 
MATERIALS AND METHODS 
Materials 
The following materials were used as received: 
Hydroxypropylmethylcellulose (HPMC K4M 4000 cps, 
pharmaceutical grade) was obtained from two different supply 
sources, A and B.  
Polyvinyl pyrrolidone (PVP K-30, pharmaceutical grade) was 
obtained from the same two different supply sources of HPMC (A 
and B) and were 
Magnesium stearate (Mg stearate) was a product of Huzhou
donated by Amipharma Laboratories Ltd. (Sudan) 
and Citypharm Pharmaceutical Industries (Sudan), respectively. 
 
Zhanwang Pharmaceutical Co., Ltd. (China) and was donated by 
Shanghai-Sudan Pharmaceutical
Model drugs used in this study (Chlorpheniramine Maleate and 
Atenolol) were pharmaceutical grade products of 




Pvt. Ltd and Ipca Laboratories Ltd (Mumbai, India), respectively, and 
were received as gift samples from Amipharma Laboratories Ltd. 
(Sudan). Other materials and reagents were analytical grade 
obtained from different commercial sources. 
Fabrication of formulations and screening within this study were 
conducted following 23 full factorial screening design (Table 1) 
where three variables, namely, supply source of HPMC, supply 
source of PVP k-30 and drug solubility were each examined at two 
possible levels to determine their effects on the physical 
performance of produced matrices through 8 experimental runs as 
presented in Table 1. 
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Preparation of matrices  
For all runs, the drug: polymer (as matrixing agent) ratio is kept 1:1 
where matrixing agent in all formulations was 1:1 mixture of HPMC 
and PVP with Mg stearate content (as a lubricant) fixed as 1% w/w. 
For each formulation run, ingredients for 200 tablets were weighed 
(Sartorius®, AG CP 124S, Germany), mixed separately using mortar 
and pestle for 10 minutes, lubricated and then compressed into tablets 
using a single punch tableting machine (Cadmach®, Ahmedabad, 
India) equipped with size 9 mm flat punch to produce matrix tablets 
with average weight of 202 mg and contain 100mg of loaded drug per 
unit dosage. The cleaning of the machine is carried out after 
preparation of each formulation run using ethanol. Each formulation 
run was separately packed in tightly closed glass bottle, labeled with 
the number of the run and evaluated for different attributes.  
Evaluation of matrix tablets 
Produced matrix tablets within all batches run were subjected to the 
following assessment:  
Friability test  
Tablets within all runs were subjected to the official friability testing 
of Ph. Eur [10] where a total of 20 tablets from each produced 
tablets batch were weighed and placed in the drum of tablet 
friability tester (Erweka, Germany). The device was turned on at 25 
round/min speed for 4 minutes. After dust removal, tablets were 
weighed and the friability was calculated using the average % loss 
from the two drums. 
Hardness test 
The test was conducted as per Ph. Eur. [10] in which 10 tablets from 
each formulation runs were placed in hardness tester (Erweka 
Gmbh, Hensenstamm, Germany). The device measures hardness in 
Newton (N) and diameter in millimeter (mm). The measured values 
and statistics of these values were calculated and recorded 
automatically by computer program connected to the device. 
Dissolution test 
Official BP dissolution method described in the general monograph 
of dissolution testing of oral dosage forms was followed for 
dissolution testing of Atenolol and Chlorpheneramine maleate 
tablets [10]. The dissolution test was carried out using basket 
apparatus (Erweka, Germany) set at 100 rpm. Dissolution medium 
was 900 ml of 0.1M HCl (pH 1.2) at 37 ± 0.5°C and 6 tablets from 
each batch were subjected to the test. Dissolution samples were 
withdrawn at predetermined time points, filtered and analyzed 
spectrophotometrically (double beam spectrophotometer, UV-1800, 
Shimadzu, Japan) either at 275 nm (for Atenolol) or 265 nm (for 
Chlorpheniramine Maleate) according to the BP specific monograph 
of each of the two drug product [11] considering sample taken at 
zero time as a blank sample. 
For each drug, concentration in dissolution samples was determined 
by refereeing to state values of absorbance of 1% solution (in 0.1M 
HCl) of reference standards of the respective drugs measured in 1 
cm length cube at the same wave length. The mean cumulative 
percentage of drug dissolved with respect to time was then 
generated for all tablet matrices. 
Drug release kinetics  
Dissolution data were subjected to model fitting and statistical 
analysis in order to explore the kinetics of the drug release. The 
model selected was power law [12] where dissolution data 
equivalent to < 60% drug release were fitted to the model to 
determine the diffusion exponent (n) which characterizes drug 
release mechanism. 
Statistical data analysis  
Values of investigated matrix properties were presented as mean ± 
SD (standard deviation). Inferential statistics relying on regression 
analysis and analysis of variance (ANOVA) followed by post-hoc 
Least Significant Difference test with a statistical significance level 
set at p < 0.05 at 95% confidence limit (CI) were used to examine the 
individual and mutual effects of investigated factors on different 
attributes of matrix tablets. Comparison between drug release 
profiles of Atenolol and chlorpheneramine maleate containing 
matrices was made using independent t'test with p < 0.05 
considered statistically significant difference. Pearson correlation 
coefficient (r) was used to evaluate the fitting strength of dissolution 
data to the power low model during determination of diffusion 
exponent of the drug release. Computations were aided by software 
computer package STATISTICA 10 (Statsofts Inc., USA) 
RESULTS AND DISCUSSION 
Table 1 summarizes formulation and processing components for 
different matrix formulations in the screening design whereas 
properties of investigated matrices are summarized in Table 2. 
 
Table 1: Composition and ingredients source for different matrix formulations 
Batch No  Drug per tablet HPMC % content and (source) PVP % content and (source)a Drug typea Mg st. b 
(% w/w) 
F1  100 mg 24.75 (B) 24.75 (B) ATN 1% 
F2 100 ~ 24.75 (A) 24.75 (B)  ATN 1% 
F3 100 ~ 24.75 (B) 24.75 (A)  ATN 1% 
F4 100 ~ 24.75 (A) 24.75 (A) ATN 1% 
F5 100 ~ 24.75 (B) 24.75 (B)  CPM 1% 
F6 100 ~ 24.75 (A) 24.75 (B) CPM 1% 
F7 100 ~ 24.75 (B) 24.75 (A) CPM 1% 
F8 100 ~ 24.75 (A) 24.75 (A) CPM 1% 
aA and B stands for the two different supply sources of both HPMC and PVP 
b
 
ATN and CPM stand for the drugs Atenolol and Chlorpheneramine maleate, respectively. 
Table 2: Properties of different matrix formulations 
Batch Friability (%) Hardness (N) DE n2 hrs * 
F1 0.12 ± 0.10 79 ± 2 0.26 ± 0.03 0.507 ± 0.033 
F2 0.02 ± 0.01 78 ± 9 0.28 ± 0.02 0.459 ± 0.008 
F3 0.05 ± 0.02 74 ± 9 0.28 ± 0.03 0.496 ± 0.101 
F4 0.17 ± 0.04 76 ± 2 0.26 ± 0.01 0.501 ± 0.191 
F5 0.20 ± 0.07 72 ± 5 0.59 ± 0.05 0.697 ± 0.095 
F6 0.35 ± 0.09 68 ± 2 0.73 ± 0.04 0.701 ± 0.084 
F7 0.05 ± 0.03 83 ± 2 0.77 ± 0.06 0.658 ± 0.119 
F8 0.05 ± 0.01 79 ± 5 0.67 ± 0.04 0.676 ± 0.049 
Values were presented as mean ± respective standard deviation.* Diffusion exponent of the drug release. 
 
 
Individual and combined influences of factors on matrix properties 
Based on the displayed properties of different matrices (Table 2), it 
might be obvious that drug solubility, supply source of HPMC and/or 
PVP revealed dissimilar effects on properties of matrices and, 
therefore, discussion will be based on the influences on these 
properties. 
Influence of factors on friability and hardness properties 
Displayed friability and hardness for different matrices were ranged 
0.02-0.45% and 68-83N, respectively (Table 2). Although CPM 
containing matrix formulations that incorporated PVP from source B 
(F5 and F6) showed higher friability values compared to other 
batches, all matrices were within the acceptable pharmacoepial limit 
for friability (< 1%) of uncoated tablets [10].  
Effect estimate charts for the investigated factors (Figure 1A,B) 
showed that the interactive setting of PVP supply source and drug 
solubility has considerable effects on matrix friability and hardness. 
Moreover, PVP supply source proved to affect only the matrix 
hardness. Furthermore, both friability and hardness were shown to 







Fig. 1: Absolute estimate of individual and pooled factors' effects on (A) friability and (B) hardness properties of produced matrix tablets 
with * and ** indicating significant effect at p < 0.05 and p < 0.01, respectively. 
 
Generally, tablet friability is a property that mostly related to the 
binder system utilized. PVP k-30 is known to possess binding 
strength that permits its application as a binder in addition to its 
function as a drug release modifier and, therefore, variation in 
supply source of PVP might be expected to affect both friability and 
hardness properties, as the result implies. The demonstrated 
variation in matrix hardness as a consequence of utilizing PVP of 
different supply sources might be attributed to the varied 
deformation properties that the two PVP might possess.  
Influences of factors on drug release characteristics 
Release profiles of ATN and CPM from their respective matrices are 
shown in Figure 2. It is clear from the figure that matrices including 
the water soluble drug CPM (F5-F8) revealed higher cumulative 
drug release, at all time intervals of the dissolution study, as 
compared to those containing the water insoluble drug ATN (F1-F4). 
Moreover, all of CPM containing matrices (F5-F8) released the 
loaded drug after 4 hrs whereas those with ATN (F1-F4) achieved 
only 50-60% drug release at that time.  
These findings encourage the assumption that drug solubility plays a 
major rule in drug release profile of these matrices which is in agree 
with relevant published works concerning the influence of drug 
solubility on the drug release from glyceryl monooleate matrix [13], 
polyethylene glycol [14] and HPMC based matrix [15]. 
It is presumed that influences of many factors on drug release from 
matrices would be more prominent during the initial phase of the 
drug release process where the rates at which the matrixing agent 
uptakes fluid and swells to form the gel layer are the determining 
processes for the drug release. Accordingly, dissolution efficiency of 
the drug at 2hr (DE2hr
Displayed values of DE
) was determined for all matrices from the 
corresponding dissolution data and used to explore the possible 
effects of investigated factors on the drug release property. 
2hr for different matrix batches were ranged 
0.26-0.77 (Table 2) and the calculated average values of DE2hr
 
 for 
ATN and CPM containing matrices (0.27 and 0.69, respectively) were 
demonstrated to be significantly varied (p= 0.0001 at 95% CI). 
 
Fig. 2: Drug release profiles of ATN containing matrices (F1-F4) 
and CPM including matrices (F5-F8). 
 
Regarding drug release kinetics, exhibited values for diffusion 
exponent of the drug release (n) for different matrix batches were 
ranged 0.459-0.701 (Table 2). The mean values of the diffusion 
exponent of drug release calculated for ATN and CPM containing 
matrices (0.491 and 0.683, respectively) were computed to be 
considerably different (p= 0.00003 at 95% CI).  
In swellable matrix tablets, the dynamics of gel layer thickness 
determine the drug release kinetics. Participation of drug diffusion, 
Nur et al. 




polymer chain relaxation and matrix erosion to drug release in 
HPMC matrices is recognized to produce n values that range from 
0.45 to 1.0 [16]. 
Although contribution of more than one mechanism in the release of 
sparingly soluble drugs from matrix tablets is well documented in 
the literature [17, 18], demonstrated values for n with ATN 
containing matrices support the fickian mechanism in which drug 
diffusion is expected to control the release process. With CPM 
matrices, however, anomalous mechanism is evident where both 
drug diffusion and polymer chain relaxation are expected to control 
the drug release. Findings related to drug release of CPM containing 
matrices are in accord with the conclusion of relevant published 
work on release kinetics of verapamil-HCl from HPMC matrices [19].  
Exhibited values of correlation coefficients associated with fitting of 
ATN and CPM release data to the power law model were ranged 
0.9903-0.9998 (p < 0.05) for all matrix formulations, indicating 
suitability of selected model for determination of diffusion exponent, 
n, of the loaded drugs.  
Among the three factors investigated for their possible impacts on 
drug release properties, only drug solubility was found to have a 
considerable influence on both DE2 hrs
The observed influence of drug solubility on DE
 and diffusion exponent (n) 
characteristics of the drug release from different matrices (p < 0.01 
at 95% CI for its effect on both properties, Figure 3A,B). 
2 hrs
  
 and n 
characteristics could be attributed to the nature of both drugs. With 
water soluble drug (CPM), the enhanced dissolution and release of 
the drug before formation of an effective polymeric gel that hinders 
the drug release would result in accelerated drug release with no (or 
a little) contribution of the gel characteristics on the release kinetics, 






Fig. 3: Absolute estimate of individual and pooled factors' effects on (A) DE2 hrs
 
 and (B) diffusion exponent characteristics of drug release 
of different matrices with ** indicating significant effect at p < 0.01. 
On the contrary, the reduced chance for the water insoluble drug 
(ATN) to escape the gel barrier, due to the expected slow dissolution 
rate of the drug, would provide a situation of a comparative low 
drug release and involvement of polymeric gel to share a role in the 
kinetics of the drug release process. 
 
 
Fig. 4: Marginal Means ± SE for DE2 hrs 
It might be obvious from Figure 4 A,B that matrix formulations 
including ATN were not affected by supply source of PVP or HPMC. 
However, with matrices incorporating CPM, formulation containing 
HPMC and PVP, both of source B (F5) revealed smaller value of DE
of Atenolol (ATN) and 
Chlorpheneramine maleate (CPM) released from different 
matrices as related to variation of HPMC and PVP supply 
sources (A and B, for each). 
2 
hrs (0.54, Table 2) as compared to that composed of PVP of source B 
and HPMC of source A (F6), which measured DE2 hrs
Nevertheless, the observed influences of supply source of PVP 
and/or HPMC on drug release of CPM containing matrices might not 
be substantial enough for statistical consideration (Figure 3 A,B)  
 of 0.76 (Table 
2). The inverse is also valid for matrices containing CPM and PVP of 
source A. 
CONCLUSION 
PVP supply source was verified to influence matrix hardness 
whereas the combined influence of PVP supply source and drug 
solubility proved to affect both matrix friability and hardness 
properties. Moreover, drug solubility demonstrated to influence 
dissolution efficiency and release kinetics properties of the prepared 
matrices. None of the investigated matrices' properties appears to 
be affected by the supply source of HPMC, at least under the present 
study conditions. 
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